Plants
Korea Plants
Daewoong Pharmaceutical has a number of strategically located manufacturing sites, each of which specializes in various production lines such as depot, liquid suspension, biologics, and etc.
Osong Plant
Chungcheongbuk-do, South Korea- Feature
- Highly automated mass production facility
- Qualified injection manufacturing facility
- Capacity: Dual Chamber Syringe (0.35M), Prefilled Syringe (0.25M), Tablet (2B)
- Area
- 40,892 m2 (440,158 ft2)
- Manufacturing Products
- Oral Solid, Depot Injection, Vial, Ampoule
Hyangnam Plant
Hyangnam, South Korea- Feature
- Main manufacturing site for oral solids, suspensions, injectables and biologics
- Produces Korea’s first new biomedicine ‘EGF’ (Epidermal Growth Factor)
- Supports clinical trial(phase 1-3) batch sizes and clinical scale-up manufacturing
- Capacity: Tablet (1B), Prefilled Syringe (1M)
- Area
- 31,735 m2 (341,598 ft2)
- Manufacturing Products
- Oral Solid, Microbial Product, Cell cultured Product
Seongnam Daewoong-Bio Plant
Seongnam, South Korea- Feature
- Top cephalosporin CMO facility
- RABS (Restricted-access barrier system) ensures sterility and validated aseptic-quality products
- Capacity: Powder Injection Filling Line (24M Vial), Tablet (100M), Capsule (100M)
- Area
- 7,535 m2 (81,106 ft2)
- Manufacturing Products
- Cephalosporin Injection, Tablet, Capsule
Anseong Daewoong-Bio Plant
Anseong, South Korea- Area
- 8,180 m2 (88,048 ft2)
- Manufacturing Products
- Oral Solid
Daejeon Plant (Hanall Biopharma)
Daejeon, South Korea- Area
- 9,011 m2 (96,993 ft2)
- Manufacturing Products
- A/A infusion, Oral Solid